Manifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 81.9%
Prévisionnistes
7
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 1 heure
En retard14 janv. 25, 02:36 UTC2 janv. 32, 07:59 UTC
Tendances
Règles
Openwater (https://openwater.health) has a device that damages cancer cells selectively with ultrasound.
- This market will resolve YES if any cancer treatment using Openwater's ultrasound technology is approved by the FDA before January 1, 2032 for one or more cancer indications.
- Any FDA approval for treating cancer outside of a clinical trial counts, even if it only covers a small set of patients.
- If Openwater's technology gets transferred to another entity, use of that technology will count as long as it involves focused ultrasound.
- I have a blog post about the treatment here: https://bayesianinvestor.com/blog/index.php/2025/01/13/openwaters-cancer-treatment/
